Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 393
7
Diseases
36
Unique genes
0.336
Avg. similarity score
Chloracne
Most-connected disease (5 links)
Disease
Searched: Rapid progression to aids from hiv1 infection
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Rapid progression to aids from hiv1 infection
Chloracne
Hemoglobin m disease
Thalassemia
Unstable hemoglobin disease
Methemoglobinemia
Heinz body anemias
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Chloracne | 5 | 5 | 33 |
| Hemoglobin m disease | 5 | 5 | 3 |
| Thalassemia | 5 | 5 | 5 |
| Unstable hemoglobin disease | 5 | 5 | 3 |
| Methemoglobinemia | 4 | 4 | 6 |
| Heinz body anemias | 3 | 3 | 2 |
| Rapid progression to aids from hiv1 infection | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| HBA2 | 6 / 7 | Chloracne, Heinz body anemias, Hemoglobin m disease, Methemoglobinemia and 2 more |
| HBB | 6 / 7 | Chloracne, Heinz body anemias, Hemoglobin m disease, Methemoglobinemia and 2 more |
| HBA1 | 5 / 7 | Chloracne, Hemoglobin m disease, Methemoglobinemia, Thalassemia and 1 more |
| CX3CR1 | 2 / 7 | Chloracne, Rapid progression to aids from hiv1 infection |
| GSTM1 | 2 / 7 | Chloracne, Thalassemia |
| HBD | 2 / 7 | Chloracne, Thalassemia |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Erythrocytes take up oxygen and release carbon dioxide | Reactome | 3 / 9 | 111× | 2.05e-6 | 6.89e-5 ✓ sig. |
| Scavenging of heme from plasma | Reactome | 3 / 13 | 77.0× | 6.93e-6 | 1.91e-4 ✓ sig. |
| Erythrocytes take up carbon dioxide and release oxygen | Reactome | 3 / 13 | 77.0× | 6.93e-6 | 1.91e-4 ✓ sig. |
| Malaria | KEGG | 4 / 50 | 26.7× | 1.42e-5 | 3.47e-4 ✓ sig. |
| Hepatocellular carcinoma | KEGG | 5 / 170 | 9.8× | 1.42e-4 | 2.27e-3 ✓ sig. |
| Pathways in cancer | KEGG | 8 / 533 | 5.0× | 1.44e-4 | 2.30e-3 ✓ sig. |
| Small cell lung cancer | KEGG | 4 / 93 | 14.3× | 1.64e-4 | 2.56e-3 ✓ sig. |
| African trypanosomiasis | KEGG | 3 / 37 | 27.0× | 1.79e-4 | 2.74e-3 ✓ sig. |
| Vitamin C (ascorbate) metabolism | Reactome | 2 / 8 | 83.4× | 2.42e-4 | 3.49e-3 ✓ sig. |
| Measles | KEGG | 4 / 139 | 9.6× | 7.59e-4 | 8.54e-3 ✓ sig. |
| Chemical carcinogenesis - DNA adducts | KEGG | 3 / 70 | 14.3× | 1.18e-3 | 1.20e-2 ✓ sig. |
| Viral myocarditis | KEGG | 3 / 70 | 14.3× | 1.18e-3 | 1.20e-2 ✓ sig. |
| Drug metabolism - cytochrome P450 | KEGG | 3 / 73 | 13.7× | 1.33e-3 | 1.31e-2 ✓ sig. |
| Melanoma | KEGG | 3 / 73 | 13.7× | 1.33e-3 | 1.31e-2 ✓ sig. |
| Non-small cell lung cancer | KEGG | 3 / 73 | 13.7× | 1.33e-3 | 1.31e-2 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| carbon dioxide transport | GO:0015670 | 5 / 13 | 200× | 2.53e-11 | 8.18e-9 ✓ sig. |
| oxygen transport | GO:0015671 | 5 / 17 | 153× | 1.21e-10 | 3.37e-8 ✓ sig. |
| erythrocyte development | GO:0048821 | 5 / 32 | 81.1× | 3.85e-9 | 7.12e-7 ✓ sig. |
| nitric oxide transport | GO:0030185 | 3 / 5 | 311× | 6.55e-8 | 8.30e-6 ✓ sig. |
| hydrogen peroxide catabolic process | GO:0042744 | 3 / 21 | 74.2× | 8.53e-6 | 4.48e-4 ✓ sig. |
| xenobiotic catabolic process | GO:0042178 | 3 / 28 | 55.6× | 2.08e-5 | 8.94e-4 ✓ sig. |
| nitrobenzene metabolic process | GO:0018916 | 2 / 4 | 260× | 2.16e-5 | 9.21e-4 ✓ sig. |
| cellular detoxification of nitrogen compound | GO:0070458 | 2 / 5 | 208× | 3.60e-5 | 1.35e-3 ✓ sig. |
| regulation of peptidyl-tyrosine phosphorylation | GO:0050730 | 2 / 6 | 173× | 5.39e-5 | 1.83e-3 ✓ sig. |
| response to hydrogen peroxide | GO:0042542 | 3 / 39 | 39.9× | 5.72e-5 | 1.91e-3 ✓ sig. |
| regulation of hematopoietic stem cell differentiation | GO:1902036 | 2 / 11 | 94.4× | 1.96e-4 | 4.74e-3 ✓ sig. |
| negative regulation of epithelial cell proliferation | GO:0050680 | 3 / 62 | 25.1× | 2.30e-4 | 5.30e-3 ✓ sig. |
| inflammatory response | GO:0006954 | 6 / 467 | 6.7× | 2.43e-4 | 5.52e-3 ✓ sig. |
| cellular oxidant detoxification | GO:0098869 | 3 / 66 | 23.6× | 2.76e-4 | 6.05e-3 ✓ sig. |
| positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | GO:0060213 | 2 / 13 | 79.9× | 2.78e-4 | 6.07e-3 ✓ sig. |
Pairs within this cluster, by significance
| Disease A ⇵ | Disease B ⇵ | Similarity score ⇵ | Shared genes ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Chloracne | Thalassemia | 0.147 | 5 | 3.20e-14 | 3.73e-13 ✓ sig. |
| Hemoglobin m disease | Unstable hemoglobin disease | 0.750 | 3 | 1.62e-12 | 1.71e-11 ✓ sig. |
| Hemoglobin m disease | Thalassemia | 0.500 | 3 | 1.62e-11 | 1.61e-10 ✓ sig. |
| Thalassemia | Unstable hemoglobin disease | 0.500 | 3 | 1.62e-11 | 1.61e-10 ✓ sig. |
| Hemoglobin m disease | Methemoglobinemia | 0.429 | 3 | 3.23e-11 | 3.15e-10 ✓ sig. |
| Methemoglobinemia | Unstable hemoglobin disease | 0.429 | 3 | 3.23e-11 | 3.15e-10 ✓ sig. |
| Methemoglobinemia | Thalassemia | 0.333 | 3 | 3.23e-10 | 2.90e-9 ✓ sig. |
| Chloracne | Hemoglobin m disease | 0.088 | 3 | 8.81e-9 | 6.96e-8 ✓ sig. |
| Chloracne | Unstable hemoglobin disease | 0.088 | 3 | 8.81e-9 | 6.96e-8 ✓ sig. |
| Heinz body anemias | Hemoglobin m disease | 0.500 | 2 | 2.50e-8 | 1.87e-7 ✓ sig. |
| Heinz body anemias | Unstable hemoglobin disease | 0.500 | 2 | 2.50e-8 | 1.87e-7 ✓ sig. |
| Heinz body anemias | Thalassemia | 0.333 | 2 | 8.34e-8 | 5.85e-7 ✓ sig. |
| Chloracne | Methemoglobinemia | 0.081 | 3 | 1.75e-7 | 1.18e-6 ✓ sig. |
| Chloracne | Rapid progression to aids from hiv1 infection | 0.029 | 1 | 2.13e-3 | 2.85e-3 ✓ sig. |